Skip to main content

Advertisement

Table 2 Life table showing estimates of risk of therapeutic failure during 28 days follow-up in cohort of P. vivax monoinfection patients from southwestern India treated with chloroquine (25 mg/kg over 3 days) followed by primaquine (0.25 mg/kg daily for 14 days)

From: Therapeutic assessment of chloroquine–primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India

Days Subjects at risk Lost to follow up Therapeutic failure IR CITF
0 125 0 0 1.00 0
2 125 0 0 1.00 0
3 125 0 1 0.99 0.01
7 124 3 0 0.99 0.01
14 121 0 0 0.99 0.01
21 121 0 0 0.99 0.01
28 121 0 0 0.99 0.01
  1. IR interval risk, CITF cumulative incidence of therapeutic failure.